Preview

Rational Pharmacotherapy in Cardiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 6, No 5 (2010) WHY BETA-BLOCKERS ARE NOT PRESCRIBED TO PATIENTS WITH HEART FAILURE AND HOW TO IMPROVE IT? Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov
"... with chronic heart failure (CHF) and to study efficacy and safety of beta-blockers therapy. Material ..."
 
Vol 17, No 5 (2021) Genetic Polymorphism of beta1-adrenergic Receptors and the Effect on the Clinical Efficacy of beta-adrenoblockers Abstract  similar documents
V. N. Larina, M. V. Leonova
"... , a reduced effect of the effect on myocardial remodeling in patients with CHF for beta-blockers in carriers ..."
 
Vol 12, No 3 (2016) PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES Abstract  PDF (Eng)  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, A. V. Zakharova, M. M. Loukianov, A. N. Vorobyev, K. A. Moseichuk, A. N. Kozminsky
"...   Aim. To assess real clinical practice of prescribing beta-blockers (BB) and its compliance ..."
 
Vol 8, No 6 (2012) TREATMENT OF CHRONIC HEART FAILURE: FOCUS ON METOPROLOL SUCCINATE Abstract  similar documents
O. D. Ostroumova, G. N. Shchukina, V. M. Fomina
"... Advantages of metoprolol succinate in patients with chronic heart failure (CHF) are covered ..."
 
Vol 4, No 3 (2008) HEART FAILURE, DIABETES, BETA-BLOCKERS AND RISK OF HYPOGLYCEMIA Abstract  similar documents
A. A. Aleksandrov, O. А. Shatskaya, S. S. Kuharenko, E. N. Drozdova, I. Z. Bondarenko, N. D. Tabidze, M. V. Shestakova
"... and various beta-blockers (atenolol, metoprolol, bisoprolol). These beta-blockers were changed for carvedilol ..."
 
Vol 19, No 6 (2023) Beta-blockers in chronic heart failure with preserved left ventricular ejection fraction: is deprescribing possible? Abstract  similar documents
V. D. Zakiev, N. M. Vorobyeva, I. P. Malaya, A. D. Gvozdeva, O. N. Tkacheva
"... use of beta-blockers in CHF patients with preserved LV EF in the absence of other indications for them ..."
 
Vol 4, No 4 (2008) BETA-ADRENOBLOCKERS IN XXI CENTURY: EPOCH END OR IMMORTALITY BEGINNING? A VIEW OF ORDINARY CARDIOLOGIST Abstract  similar documents
L. N. Malaj
"... Usage of β-blockers (BB) for treatment of patients with cardiovascular diseases is discussed ..."
 
Vol 6, No 6 (2010) THE CHOICE OF DRUG FROM THE STANDPOINT OF EVIDENCE-BASED MEDICINE: CASE STUDY OF BETA-BLOCKERS Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, Yu. V. Lukina
"... Basic principles of beta-blockers choice strategy are presented. Attention is focused on the facts ..."
 
Vol 8, No 1 (2012) BETA-BLOCKERS IN THE TREATMENT OF ARTERIAL HYPERTENSION: EVIDENCE BASED DATA AND REAL PRACTICE Abstract  similar documents
M. V. Leonova
"... Data of the largest meta-analyzes of beta-blockers use in arterial hypertension is presented ..."
 
Vol 13, No 4 (2017) CLINICAL PRACTICE OF BETA-BLOCKERS USAGE IN PATIENTS WITH CARDIOVASCULAR AND CHRONIC RESPIRATORY DISEASES. DATA OF OUTPATIENT REGISTRIES PROFILE AND RECVASA Abstract  similar documents
S. Yu. Martsevich, N. A. Zakharova, N. P. Kutishenko, A. V. Zagrebelnyy, Yu. V. Lukina, M. M. Loukianov, A. N. Vorobyev, A. N. Kozminsky
"... Aim. To assess the practice of using beta-adrenoblockers (β-AB) in patients with cardiovascular ..."
 
Vol 3, No 5 (2007) EFFECTS OF BETA-BLOCKER METOPROLOL ON QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
I. V. Vologdina
"... formulation) on quality of life in elderly patients with chronic heart failure (CHF) of ischemic etiology ..."
 
Vol 6, No 5 (2010) EFFECT OF BETA-BLOCKERS ON BLOOD PRESSURE, PERIOPERATIVE COMPLICATIONS AND HOSPITAL STAY DURATION IN PATIENTS WITH INTERMEDIATE RISK OF CARDIOVASCULAR COMPLICATIONS AFTER ROUTINE CHOLECYSTECTOMY: AN OPEN COMPARATIVE RANDOMIZED STUDY Abstract  similar documents
O. L. Barbarash, R. V. Repnikova, T. V. Shoforus, O. I. Golofaeva
"... . To evaluate the efficacy and safety of beta-blocker bisoprolol in the perioperative period in hypertensive ..."
 
Vol 15, No 5 (2019) Possibilities of Combination of Beta-blockers and Ivabradine in Patients with Stable Angina Pectoris Abstract  similar documents
V. V. Kashtalap, O. L. Barbarash, D. Yu. Sedykh, K. E. Krivoshapova, D. P. Tsygankova, O. V. Tsygankova
"... Aim. To evaluate the therapeutic efficacy of a combination of ivabradine and beta-blockers (BAB ..."
 
Vol 17, No 5 (2021) Peculiarities of Adverse Events Manifested by Injury of Skin and Skin Derivatives and Associated with Beta-blockers Use Abstract  similar documents
A. V. Matveev, E. A. Egorova, E. I. Konyaeva, A. G. Dormidor, E. Yu. Bekirova
"... that can lower the heart rate, beta-blockers (BAB) are still widely used in the pharmacotherapy ..."
 
Vol 20, No 5 (2024) Early intravenous beta-blockers injection in patients with acute STEMI: the results of the Russian registry REGION-IM Abstract  similar documents
T. S. Sukhinina, M. A. Terenicheva, R. G. Gulyan, R. M. Shakhnovich, O. V. Stukalova, O. A. Saygina, I. S. Yavelov, D. V. Pevsner
"... Aim. To study the features of the appointment of beta-blockers (BB) therapy in the early stages ..."
 
Vol 8, No 4 (2012) HIGH SELECTIVE LONG-ACTING Β1-BLOCKER WITH A VASODILATING EFFECT NEBIVOLOL IN PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE Abstract  similar documents
V. P. Lupanov
"... Review is devoted to the role of modern beta-blocker nebivolol in the treatment of stable ischemic ..."
 
Vol 5, No 1 (2009) COMPARISON OF THERAPIES BASED ON CARVEDILOL AND METOPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY. THE FIRST RESULTS OF CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Velishanina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P. Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiseleva, S Yu. Levashov, V. A. Nevsorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnyukova, V. V. Yakusevich, E. N. Akulina, V. A. Budanova, T. S. Bondarenko, V. P. Voronina, I. N. Gozhaja, I. I. Igricenco, A. V. Drogan, N. A. Dmitrieva, F. M. Dyshekova, A. I. Zaiceva, A. N. Ikovnikova, G. A. Ilicheva, I. S. Irhina, L. A. Kovaleva, O. N. Kutkina, E. A. Kudrjashev, A. Z. Leonidova, E. N. Loginova, M. P. Marganjan, O. V. Nastradin, A. N. Nikitina, I. N. Nikolskaja, I. E. Pashinceva, A. S. Petrochenko, O. M. Pasnenkova, E. S. Potapova, A. A. Serazhim, M. N. Sergeev, V. V. Sidorenko, V. A. Simonov, D. V. Sirotenko, I. N. Spanderashvili, A. N. Strunina, E. S. Timoschenko, S. N. Tolpygina, M. R. Redkina
"... received C 12,5 mg BID (Vedicardol, “Sintez”), another part – M 25 mg/day BID. Doubling dose of β-blockers ..."
 
Vol 5, No 2 (2009) COMPARISON OF THE METABOLIC EFFECTS OF CARVEDILOL AND METОPROLOL IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT AND OBESITY. THE CAMELLIA TRIAL Abstract  similar documents
S. Y. Martsevich, N. P. Kutishenko, E. V. Shilova, A. D. Deev, S. A. Shalnova, R. G. Oganov, I. A. Veliganina, E. G. Volkova, Yu. E. Voskanjan, L. I. Gapon, P Ya. Dovgalevskij, V. Ya. Ermolina, E. M. Idrisova, N. N. Ilov, A. R. Kiselev, S. Yu. Levashov, V. A. Nevzorova, G. I. Nechaeva, T. N. Panova, I. I. Reznik, V. V. Skibickij, L. A. Sokolova, V. P. Terentev, N. V. Hailo, A. V. Shabalin, T. V. Shnjukova, V. V. Yakusevich
"... Цель. Сравнить два варианта терапии бета-адреноблокаторами (БАБ), основанных на карведилоле или ..."
 
Vol 9, No 5 (2013) PRIMARY CARE PROBLEMS IN PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
O. A. Shtegman
"... received target doses of ACE inhibitors/sartans and beta-blockers, respectively. Majority of CHF ..."
 
Vol 4, No 3 (2008) ROLE OF BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION TREATMENT. WHAT DO EVIDENCE BASED MEDICINE DATA SHOW? Abstract  similar documents
S. Y. Martsevich
"... The beta-blocker role in arterial hypertension treatment is surveyed from the positions of evidence ..."
 
Vol 1, No 3 (2005) CARDIORENAL RELATIONS AND QUALITY OF LIFE IN ELDERLY PATIENTS WITH CHRONIC HEART FAILURE IN LONG TERM THERAPY WITH CARVEDILOL AND BISOPROLOL Abstract  similar documents
M. A. Statsenko, I. A. Sporova, S. V. Belenkova, N. N. Shilina
"... including both beta-blockers resulted in clinical improvement, increase in myocardial contractility. However ..."
 
Vol 13, No 3 (2017) BETA-BLOCKERS AND RENOPROTECTION: THE POTENTIAL OF CARVEDILOL Abstract  similar documents
I. T. Murkamilov, I. S. Sabirov, V. V. Fomin, F. A. Yusupov
"... -blockers, the use of beta-adenoblocker with vasodilating activity, in particular carvedilol, makes ..."
 
Vol 17, No 3 (2021) Heart Failure with Perserved Ejection Fraction Current Diagnostic and Therapeutic Approaches Abstract  similar documents
A. A. Shchendrygina, K. A. Zhbanov, E. V. Privalova, A. O. Yusupova, Yu. A. Danilogorskaya, E. Yu. Salakheeva, I. Ya. Sokolova, S. A. Tsatsurova, A. A. Ageeva, Yu. N. Belenkov
 
Vol 4, No 3 (2008) URODYNAMIC EFFECTS OF BETA-ADRENOBLOCKERS: NEBIVOLOL ADVANTAGES Abstract  similar documents
M. P. Savenkov, A. S. Volkova, A. V. Kirienko, S. N. Ivanov, S. V. Ivanov
"... Aim. To compare urodynamic effects of beta-blockers with different selectivity (propranolol ..."
 
Vol 4, No 2 (2008) BETA-ADRENOBLOCKERS AND PLATELET AGGREGATION. CARVEDILOL Abstract  similar documents
A. N. Zakirova, F. S. Zarudij, B. N. Garifullin
"... Approaches evolution to studying of beta-blockers influence on platelet aggregation is reviewed ..."
 
Vol 6, No 1 (2010) THE BISOPROLOL — A HIGH SELECTIVE BETA-BLOCKER ACCORDING TO EVIDENCE BASED MEDICINE Abstract  similar documents
Yu. V. Lukina, S. Yu. Martsevich
 
Vol 11, No 6 (2015) The first Russian register of patients with chronic heart failure and atrial fibrillation (RIF-CHF): study design Abstract  similar documents
S. N. Tereshchenko, I. V. Zhirov, N. V. Romanova, Yu. F. Osmolovskaya, S. P. Golitsyn
"... Chronic heart failure (CHF) and atrial fibrillation (AF) can rightly be called the epidemic ..."
 
Vol 16, No 3 (2020) Angiogenesis in Patients with Chronic Heart Failure: Focus on Endothelial Vascular Growth Factor, Pentraxin-3 and Transforming Growth Factor Beta Abstract  similar documents
R. N. Shepel, O. M. Drapkina
"... Chronic heart failure (CHF) is considered the leading cause of death in patients with established ..."
 
Vol 7, No 3 (2011) TREATMENT OPTIMIZATION IN PATIENTS WITH STABLE ANGINA PECTORIS: FOCUS ON VERAPAMIL SR Abstract  similar documents
I. M. Sokolov
"... medications that slow down HR: beta blockers (BB), If-channel inhibitors, nondihydropyridine calcium channel ..."
 
Vol 13, No 2 (2017) PATIENTS WITH COMBINATION OF CHRONIC HEART FAILURE, HYPERTENSION AND HISTORY OF MYOCARDIAL INFARCTION: CLINICAL AND ANAMNESTIC CHARACTERISTICS, ADMINISTRATION OF ACE INHIBITORS, ANGIOTENSIN RECEPTOR BLOCKERS, -BLOCKERS AND ADHERENCE TO THE DRUG THERAPY (DATA OF OUTPATIENT REGISTRY RECVASA) Abstract  similar documents
M. M. Loukianov, A. N. Kozminsky, S. Yu. Martsevich, S. S. Yakushin, A. N. Vorobyev, A. V. Zagrebelnyy, R. P. Myasnikov, K. G. Pereverzeva, E. A. Pravkina, E. Yu. Andreenko, E. N. Belova, A. D. Deev, V. G. Klyashtorny, E. V. Kudryashov, S. A. Boytsov
"... and stroke history, more severe course of CHF, HT and IHD, greater prescription rate of β-blockers ..."
 
Vol 5, No 4 (2009) METOPROLOL AND CARVEDILOL IN THERAPY OF ACUTE MYOCARDIAL INFARCTION: WHEN AND WHICH DRUG TO PREFER Abstract  similar documents
B. N. Garifullin, A. N. Zakirova, F. S. Zarudij
"... Results of large randomized clinical trails on beta-blockers therapy of myocardial infarction (MI ..."
 
Vol 7, No 2 (2011) SUDDEN CARDIAC DEATH: PROBLEM OF RISK STRATIFICATION AND CHOICE OF THERAPY Abstract  similar documents
E. V. Filippov, S. S. Yakushin
"... is pharmacotherapy. Overview of various drugs is given. The largest evidence base and proven efficacy have beta ..."
 
Vol 13, No 6 (2017) THE ROLE OF CARVEDILOL IN THE PREVENTION OF CARDIOMYOCYTE APOPTOSIS CAUSED BY ACUTE MYOCARDIAL INFARCTION Abstract  similar documents
A. N. Zakirova, B. N. Garifullin, N. E. Zakirova
"... in experimental data. Carvedilol is a third-generation beta-blocker with additional pleiotropic and antioxidant ..."
 
Vol 6, No 6 (2010) THE POSSIBILITIES OF ANTIARRHYTHMIC THERAPY IN PRIMARY PREVENTION OF DEATH IN PATIENTS WITH VENTRICULAR ARRHYTHMIAS Abstract  similar documents
Yu. A. Bunin
"... and VA only beta-blockers and amiodarone are able to reduce mortality, while other drugs have no effect ..."
 
Vol 9, No 4 (2013) USE OF BETA-BLOCKERS IN THE PERIOPERATIVE PERIOD: HOW STRONG ARE THE EVIDENCES? Abstract  similar documents
V. V. Samoylenko, O. P. Shevchenko, V. I. Burtsev
"... attention has recently been focused on the use of beta-blockers in the postoperative period. Nowadays ..."
 
Vol 9, No 5 (2013) THE ASSESSMENT AND REDUCTION OF CARDIAC EVENTS RISK IN NONCARDIAC OPERATIONS: IS THERE A NEED FOR REVIEW OF RECOMMENDATIONS? Abstract  similar documents
A. N. Sumin
"... the available scientific evidence. In this review we discussed in detail the use of beta-blockers in noncardiac ..."
 
Vol 8, No 4 (2012) EFFECT OF CARDIOVASCULAR DRUGS ON BONE HEALTH AND THE POSSIBILITY OF THEIR USE FOR THE PREVENTION OF OSTEOPOROSIS Abstract  similar documents
I. A. Skripnikova, K. E. Sobchenko, O, V. Kosmatova, D. V. Nebieridze
"... and, first of all beta-blockers, ACE inhibitors, diuretics, and statins on bone are presented. Mode of action ..."
 
Vol 18, No 6 (2022) The Effect of Angiotensin Receptor and Neprilysin Inhibitors on Quality of Life in Patients with Heart Failure with Reduced Ejection Fraction and Functional Mitral Regurgitation Abstract  similar documents
A. S. Ryazanov, E. V. Shikh, O. V. Kechina, M. V. Makarovskaya, A. A. Kudryavtsev
"... parameters in patients with chronic heart failure (CHF) and functional mitral regurgitation (FMR) under ..."
 
Vol 18, No 2 (2022) Damage to the Cardiovascular System in Patients with SARS-CoV-2 Coronavirus Infection. Part 2: Correction of Myocardial Systolic Dysfunction Abstract  similar documents
V. I. Podzolkov, A. I. Tarzimanova, A. E. Bragina, I. I. Shvedov, E. E. Bykova, A. A. Ivannikov, L. V. Vasilyeva
"... of chronic heart failure (CHF). Materials and methods. The study included 90 hospitalized patients ..."
 
Vol 17, No 3 (2021) Comparative Characteristics of Beta-Blockers in Patients with Congenital Long QT Syndrome Abstract  similar documents
A. Yu. Proshlyakov, P. Sh. Chomakhidze, N. A. Novikova
"... . A positive result of treatment depends on the severity of long QT syndrome and its genotype. Beta-blockers ..."
 
Vol 8, No 5 (2012) THE ROLE OF BETA-BLOCKERS IN THE TREATMENT OF CARDIOVASCULAR DISEASES IN PREGNANT WOMEN Abstract  similar documents
R. I. Striuk, Ya. V. Brytkova
 
Vol 6, No 2 (2010) NEBIVOLOL – ESPECIAL BETA-ADRENOBLOCKER Abstract  similar documents
T. Műnzel, T. Gori
"... . Nebivolol. The somewhat-different β-adrenergic receptor blocker was initially published in J Am Coll Cardiol ..."
 
Vol 9, No 3 (2013) THE ROLE OF S-AMLODIPINE IN ARTERIAL HYPERTENSION THERAPY WITH COMBINATION OF CALCIUM CHANNEL BLOCKERS AND BETA-BLOCKERS Abstract  similar documents
M. A. Maksimova, Yu. V. Lukina, S. Yu. Martsevich
"... Aim. To study efficacy and safety of calcium channel blocker, S-amlodipine, in combination with β ..."
 
Vol 17, No 5 (2021) Study of the Quality of Medical Therapy and Adherence in Patients with Chronic Heart Failure (According to the COMPLIANCE Study) Abstract  PDF (Eng)  similar documents
E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih, O. M. Drapkina, S. Yu. Martsevich
"... with CHF. Results. According to the results of the study, beta-blockers were prescribed to 70 (97 ..."
 
Vol 14, No 1 (2018) COMPARATIVE ANALYSIS OF HOSPITAL PHARMACOTHERAPY OF CHRONIC HEART FAILURE WITH REDUCED LEFT VENTRICULAR EJECTION FRACTIONS IN 2009-2010 AND 2014-2015 Abstract  similar documents
O. V. Reshetko, A. V. Sokolov, E. V. Rykalina, N. V. Furman
"... of combination therapy in 2014-2015, the frequency of the prescription of the ACE inhibitor+beta-blocker and ACE ..."
 
Vol 12, No 2 (2016) ENDOTHELIAL DYSFUNCTION AND ROLE NITRATES AND BETA-BLOCKERS IN ITS CORRECTION IN ISCHEMIC HEART DISEASE Abstract  similar documents
A. N. Britov
"... . The treating effect of some medicinal products (nitrates, beta-blockers and others) is analyzed from the point ..."
 
Vol 5, No 4 (2009) BISOPROLOL EFFICACY IN PATIENTS WITH ARTERIAL HYPERTENSION ASSOCIATED WITH CARDIOPULMONARY DISEASES Abstract  similar documents
G. N. Gorokchovskaya, M. M. Petina
"... Beta-blockers application in modern cardiologic practice is reviewed with focus on beta-blocker ..."
 
Vol 7, No 2 (2011) A COMPARATIVE STUDY OF THE EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN MONOTHERAPY OR IN COMBINATION WITH S-AMLODIPINE AND INDAPAMIDE IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 DEGREES. RESULTS OF THE CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, I. V. Vashurina
 
Vol 13, No 2 (2017) SECONDARY PREVENTION IN PATIENTS AFTER MYOCARDIAL INFARCTION AT AMBULATORY SPECIALIZED CARDIOLOGY INSTITUTION (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. B. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, D. A. Dimitrova
"... recommended for patients with a history of myocardial infarction (antiplatelets – 91.76%, beta-blockers – 83 ..."
 
Vol 10, No 4 (2014) TREATMENT OF HYPERTENSION IN PREGNANCY: GUIDELINES AND CLINICAL EXPERIENCE Abstract  similar documents
O. V. Gaisenok, O. A. Zamyatina, N. Yu. Denisova, A. S. Leonov
 
Vol 3, No 3 (2007) COMPARATIVE EVALUATION OF EFFICACY AND TOLERABILITY OF ORIGINAL AND GENERIC BISOPROLOL IN PATIENTS WITH ARTERIAL HYPERTENSION 1-2 GRADE Abstract  similar documents
S. N. Tolpygina, E. V. Shilova, S. Y. Martsevich
 
Vol 16, No 4 (2020) Evaluating Adherence to Medical Therapy in Patients with Chronic Heart Failure: Design and First Results of the COMPLIANCE Study Abstract  similar documents
S. Yu. Martsevich, E. T. Guseynova, N. P. Kutishenko, Yu. V. Lukina, S. N. Tolpygina, V. P. Voronina, S. V. Blagodatskih
"... (ACEI)/angiotensin receptor blockers (ARB). Beta-blockers (BB) were prescribed to 96.7% of patients ..."
 
Vol 3, No 1 (2007) CHRONIC HEART FAILURE AND IRON-DEFICIENT ANEMIA Abstract  similar documents
M. V. Melnik, A. M. Shilov, I. R. Kim, O. N. Retivykh, A. A. Saricheva
"... CHF therapy (angiotensin converting enzyme inhibitors, β-emblockers/em, diuretics, cardiac glycosides ..."
 
Vol 17, No 3 (2021) Left Atrial Function in Different Modes of Heart-Rate Lowering Therapy with Beta-Blockers in Patients with Recurrent Atrial Fibrillation and Hypertension Abstract  similar documents
E. V. Kokhan, G. K. Kiyakbaev, E. M. Ozova, V. A. Romanova, Zh. D. Kobalava
"... Aim. To study the impact of heart rate (HR) reduction with embeta/em-emblockers/em (BB) on left atrial (LA ..."
 
Vol 7, No 1 (2011) TIMING OF PRE-OPERATIVE BETA-BLOCKER TREATMENT IN VASCULAR SURGERY PATIENTS: INFLUENCE ON POST-OPERATIVE OUTCOME  similar documents
W.-J. Flu, J.-P. van Kuijk, M. Chonchol, T. A. Winkel, H.J.M. Verhagen, J. J. Bax, D. Poldermans
 
Vol 5, No 5 (2009) EFFICACY AND SAFETY OF VASOACTIVE BETA-BLOCKERS IN ACUTE PHARMACOLOGICAL TEST IN HYPERTENSIVE PATIENTS OF DIFFERENT AGES Abstract  similar documents
O. V. Fedorishina, A. A. Dzizinsky, K. V. Protasov, V. A. Protasova, T. I. Kucherova, E. G. Zakharova, D. D. Baskhaeva, T. S. Sukhoroslova, O. V. Perkova
 
Vol 6, No 2 (2010) CLINICAL APPROACHES TO INTERPRETATION OF CLINICAL TRAILS RESULTS ON BETA-BLOCKERS FOR THE TREATMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. R. Giljarevskiy, I. M. Kuzmina
"... Modern approaches to a choice of embeta/em-emblockers/em for treatment of patients with chronic heart ..."
 
Vol 9, No 3 (2013) PROBLEMS AND PROSPECTS OF INTERMEDIARY METABOLISM CORRECTION IN PATIENTS WITH VASCULAR COMORBIDITY Abstract  similar documents
S. A. Rumyantseva, R. G. Oganov, V. A. Stupin, E. V. Silina, A. S. Orlova, S. B. Bolevich, V. V. Afanasev, E. N. Kabaeva, S. A. Volik
"... correcting therapy including embeta/em-oxidation emblocker/em (meldonium) is discussed. ..."
 
Vol 9, No 6 (2013) COMPARATIVE EFFICACY OF CHRONIC HEART FAILURE TREATMENT WITH PERINDOPRIL OR CARVEDILOL IN PATIENTS WITH ALCOHOLIC OR IDIOPATHIC DILATED CARDIOMYOPATHY Abstract  similar documents
I. V. Zhirov, G. K. Sarbalinova, S. N. Tereschenko
"... or embeta/em-emblocker/em carvedilol in patients with chronic heart failure (emCHF/em) due to dilated cardiomyopathy ..."
 
Vol 7, No 5 (2011) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Abstract  similar documents
S. Yu. Martsevich, N. P. Kutishenko, V. A. Egorov, A. V. Zagrebel'nyy, A. A. Serazhim, Yu. V. Lukina, N. A. Dmitrieva
 
Vol 7, No 6 (2011) EFFECT OF METOPROLOL THERAPY ON THE ARTERIAL STIFFNESS Abstract  similar documents
V. E. Oleynikov, I. B. Matrosova, Y. A. Tomashevskaya, L. I. Gusakovskaya, E. A. Melnikova
 
Vol 9, No 5 (2013) TREATMENT OF PATIENTS WITH CHRONIC ISCHEMIC HEART DISEASE IN REAL CLINICAL PRACTICE ACCORDING TO THE DATA FROM PROGNOZ IBS REGISTER (PART 2) Abstract  similar documents
S. N. Tolpygina, Yu. N. Polyanskaya, S. Yu. Martsevich
"... hospital. In specialized hospital the rate of aspirin use increased by 30%, statins - by 80%, embeta/em-emblockers/em ..."
 
Vol 9, No 5 (2013) A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF GENERIC AND ORIGINAL LOW-DOSE BISOPROLOL/HYDROCHLOROTHIAZIDE COMBINATION IN PATIENTS WITH ARTERIAL HYPERTENSION OF 1-2 DEGREES. RESULTS OF CLINICAL RANDOMIZED CROSSOVER STUDY Abstract  similar documents
S. Yu. Martsevich, S. N. Tolpygina, A. V. Zakharova, V. P. Voronina, O. V. Lerman, Yu. V. Lukina, N. A. Dmitrieva, N. V. Kiseleva
 
Vol 1, No 1 (2005) DRUGS AND SMOKING Abstract  similar documents
J. V. Lukina
"... in smokers. Aim. To compare efficacy and safety of selective and non-selective embeta/em–adrenoceptor emblockers/em ..."
 
Vol 14, No 2 (2018) FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY) Abstract  similar documents
S. В. Fitilev, I. I. Shkrebneva, A. V. Vozzhaev, K. O. Tsukanova
"... in patients with stable angina significantly increased: antiplatelets – up to 82.7%, embeta/em-emblockers/em – up to 74 ..."
 
Vol 12, No 1 (2016) Pharmacoeconomic analysis of heart rate slowing drugs in patients with ischemic heart disease Abstract  similar documents
E. I. Tarlovskaya, T. I. Chudinovskikh
 
Vol 15, No 1 (2019) Atherosclerosis and Osteoporosis. Common Targets for the Effects of Cardiovascular and Anti-osteoporotic Drugs (Part I). The Effect of Cardiovascular Drugs on Bone Strength Abstract  similar documents
I. A. Skripnikova, N. A. Alikhanova, M. A. Kolchinа, M. A. Myagkova, O. V. Kosmatova
"... of cardiovascular drugs, such as statins, embeta/em-emblockers/em, ACE inhibitors, diuretics, calcium antagonists and nitrates ..."
 
Vol 17, No 3 (2021) Chronic Heart Failure in Patients with Arterial Hypertension Associated with Obstructive Sleep Apnea Syndrome: Possible Options to Pathogenetic Therapy Abstract  similar documents
A. V. Yakovlev, S. N. Shilov, E. N. Berezikova, N. F. Yakovleva, A. T. Teplyakov, E. V. Grakova, K. V. Kopeva, I. A. Efremov
"... is at least 2 years. Patients received drug therapy, including embeta/em-emblockers/em, mineralocorticoid receptor ..."
 
Vol 5, No 1 (2009) ONCE AGAIN ABOUT BETA-ADRENOBLOCKERS IN ARTERIAL HYPERTENSION. WHAT SHOULD DOCTOR RECOMMEND TO THE PATIENT? Abstract  similar documents
S. Y. Martsevich
"... The role of embeta/em-emblockers/em (BB) in arterial hypertension therapy is discussed from the evidence ..."
 
Vol 3, No 4 (2007) EFFECTS OF Β-ADRENOBLOCKERS ON MYOCARDIAL REMODELING, IMMUNO-INFLAMMATORY REACTIONS AND ENDOTHELIAL DYSFUNCTION IN PATIENTS WITH ISCHEMIC HEART DISEASE AND CHRONIC HEART FAILURE Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, I. M. Karamova, N. Kh. Khafizov, O. V. Rasskazova
"... reactions and endothelial dysfunction in patients with ischemic heart disease and chronic heart failure (emCHF/em ..."
 
Vol 6, No 1 (2010) ANTIHYPERTENSIVE EFFICACY AND VASOPROTECTIVE PROPERTIES OF A NEW COMBINATION OF BETA-BLOCKER, BISOPROLOL (2,5/5 MG) AND DIURETIC, HYDROCHLOROTHIAZIDE (6,25 MG) Abstract  similar documents
O. D. Ostroumova, A. G. Sazonova, K. U. Reznikova, A. V. Srednjakov, E. A. Smolyarchuk
"... of selective embeta/em1-adrenoblocker (BIS 2.5-5 mg) and diuretic (HCT 6,25 mg). Initially and in 12 weeks ..."
 
Vol 16, No 5 (2020) Comparative Characteristics of Patients with Cerebral Stroke and Myocardial Infarction in Outpatient Practice: Structure of Comorbidity, Risk Factors, Drug Treatment and Outcomes Abstract  similar documents
A. N. Vorobyev, K. G. Pereverzeva, M. M. Loukianov, S. S. Yakushin, S. Yu. Martsevich, E. Yu. Okshina, O. M. Drapkina
"... receptor emblockers/em (ARBs) in emCHF/em, embeta/em-emblockers/em in emCHF/em and MI history, statins in CHD, antiplatelet agents ..."
 
Vol 14, No 2 (2018) PHARMACOECONOMIC ANALYSIS OF CHRONIC HEART FAILURE DRUG THERAPY IN PATIENTS WITH COMORBID CONDITIONS Abstract  similar documents
S. K. Zyryanov, A. E. Cheberda, D. Yu. Belousov
"... Aim. To perform pharmacoeconomic analysis of emCHF/em therapy with supramolecular sacubitril/valsartan ..."
 
Vol 4, No 2 (2008) MILDRONATE EFFECT ON ENDOTHELIUM-DEPENDENT VASODILATION IN PATIENTS WITH CHRONIC HEART FAILURE: DOUBLE BLIND CROSSOVER STUDY Abstract  similar documents
L. G. Voronkov, A. A. I.Shkurat, E. A. Lutsak
"... failure (emCHF/em). Material and methods. 30 patients with emCHF/em taking standard therapy (diuretic, ACE ..."
 
Vol 7, No 3 (2011) EFFECT OF THERAPEUTIC TRAINING AND ACTIVE OUTPATIENT MANAGEMENT ON CLINICAL STATE AND CARDIOVASCULAR COMPLICATIONS IN PATIENTS WITH CHRONIC HEART FAILURE (THREE YEAR FOLLOW-UP) Abstract  similar documents
A. P. Rebrov, N. A. Kosheleva
"...   (emCHF/em)  during  three year follow-up. Material and methods. A total of 211 patients with emCHF/em experienced ..."
 
Vol 9, No 1 (2013) MYOCARDIAL FIBROSIS IN PATIENTS WITH DIABETES MELLITUS Abstract  similar documents
O. M. Drapkina, B. B. Gegenava
 
Vol 14, No 4 (2018) Atrial Fibrillation and Ventricular Arrhythmias in ST Segment Elevation Myocardial Infarction: Possibilities of Pharmacotherapy and Non-Pharmacological Treatment Abstract  similar documents
Yu. A. Bunin, S. A. Miklisanskaya, V. V. Chigineva, E. A. Zolozova
"... revascularization, radiofrequency catheter ablation, normalization of electrolyte imbalance, use of embeta/em-emblockers/em ..."
 
Vol 3, No 1 (2007) RATIONAL CHOICE OF Β-ADRENOBLOCKERS IN CHRONIC HEART FAILURE THERAPY Abstract  similar documents
M. L. Maximov
"... heart failure (emCHF/em) as well as data of own study on nebivolol efficacy and tolerability in 113 patients ..."
 
Vol 21, No 1 (2025) Physicians’ knowledge of therapy that affecting the prognosis of patients with chronic heart failure Abstract  similar documents
N. B. Perepech, I. E. Mikhailova, A. V. Tregubov
"... - converting enzyme inhibitor /angiotensin II receptor emblocker/em + embeta/em-emblocker/em (BB) + mineralocorticoid receptor ..."
 
Vol 20, No 4 (2024) The evolution of evidence-based methods of acute myocardial infarction treatment: is there any reason for optimism in recent years? Abstract  similar documents
S. Yu. Martsevich
"... that none of these studies gave a positive result. A new study with embeta/em-emblockers/em, which proved its positive ..."
 
Vol 12, No 1 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  PDF (Eng)  similar documents
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, N. N. Nikulina, K. G. Pereverzeva, E. A. Pravkina, A. D. Deev, E. V. Kudryashov, E. N. Belova
"... was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor emblockers/em (ARB) and embeta/em ..."
 
Vol 5, No 3 (2009) ANGIOTENSIN CONVERTING ENZYME INHIBITORS IN MANAGEMENT OF PATIENTS WITH CHRONIC HEART FAILURE Abstract  similar documents
S. N. Tereshchenko, N. A. Dzhaiani
"... The role of ACE inhibitors in modern pharmacotherapy of patients with chronic heart failure (emCHF/em ..."
 
Vol 10, No 3 (2014) NEW EMPHASES ON THE STUDY OF THE PATHOGENESIS OF CHRONIC HEART FAILURE WITH PRESERVED EJECTION FRACTION: FOCUS ON INFLAMMATORY MARKERS Abstract  similar documents
O. M. Drapkina, L. O. Palatkina
"... with the severity of chronic heart failure (emCHF/em). Increasing number of patients with symptoms of emCHF/em but without ..."
 
Vol 12, No 6 (2016) HEART FAILURE AND DIABETES MELLITUS: SELECTED ISSUES OF ETIOLOGY AND PATHOGENESIS, PROGNOSIS AND TREATMENT Abstract  similar documents
B. U. Mardanov, M. N. Korneeva, E. B. Akhmedova
"... of chronic heart failure (emCHF/em) and diabetes mellitus (DM). The modern views on the epidemiology, pathogenesis ..."
 
Vol 15, No 5 (2019) Patients with History of Myocardial Infarction and Acute Cerebrovascular Accidentin Clinical Practice: Demographic, Clinical Characteristics, Drug Treatment and Outcomes (Data of Outpatient and Hospital Registry REGION) Abstract  similar documents
E. Yu. Okshina, M. M. Loukianov, S. Yu. Martsevich, S. S. Yakushin, N. P. Kutishenko, A. N. Vorobyev, K. G. Pereverzeva, A. V. Zagrebelnyy, V. P. Voronina, N. A. Dmitrieva, O. V. Lerman, E. V. Kudryashov, S. A. Boytsov, O. M. Drapkina
"... -emblockers/em in emCHF/em – 39% and 23.8% (p=0.002), respectively. During 4- year follow-up in the group ACVA+MI ..."
 
Vol 7, No 5 (2011) THE ADHERENCE TO RECOMMENDED THERAPY IN PATIENTS AFTER ACUTE CORONARY SYNDROME, AND RISK OF CARDIOVASCULAR COMPLICATIONS WITHIN A YEAR AFTER HOSPITAL ADMISSION Abstract  similar documents
N. F. Puchin'yan, Ya. P. Dovgalevskiy, P. V. Dolotovskaya, N. V. Furman
"... . Complex therapy (acetylsalicylic acid (ASA), embeta/em-emblockers/em (BB), ACE inhibitors, statins) was prescribed ..."
 
Vol 12, No 6 (2016) CONCOMITANT CARDIOVASCULAR DISEASES AND ANTIHYPERTENSIVE TREATMENT IN OUTPATIENT PRACTICE (BY THE RECVASA REGISTRY DATA) Abstract  similar documents
M. Loukianov
"... was 26.1%. We have noted insufficient ACE inhibitors/angiotensin receptor emblockers/em (ARB) and embeta/em ..."
 
Vol 2, No 4 (2006) “CYTOKINE” MODEL OF PATHOGENESIS OF CHRONIC HEART FAILURE AND THE OPPORTUNITIES OF NEW THERAPEUTIC STRATEGY IN DECOMPENSATED PATIENTS Abstract  similar documents
U. A. Vasuk, O. P. Dudarenko, E. N. Uschuk, E. L. Schkolnik, M. K. Serova
"... Neurohumoral model of pathogenesis of chronic heart failure (emCHF/em) made it possible to develop new ..."
 
Vol 8, No 4 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART I) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpygina
"... a dose of a embeta/em-emblocker/em was doubled, then amlodipine was added in the dose of 5 mg daily with its ..."
 
Vol 14, No 3 (2018) COMPARATIVE PHARMACOEPIDEMIOLOGICAL ASSESSMENT OF ANTIHYPERTENSIVE DRUGS PRESCRIPTION IN OUTPATIENT PRACTICE IN KURSK AND CHISINAU Abstract  similar documents
S. V. Povetkin, O. V. Levashova, V. I. Ghicavii, N. G. Batchinschi, L. A. Pjdgurschi, L. M. Turca
"... more often embeta/em-adrenoblockers (BAB), somewhat less often – angiotensinconverting enzyme (ACE ..."
 
Vol 9, No 1 (2013) OUTPATIENT REGISTER OF CARDIOVASCULAR DISEASES IN THE RYAZAN REGION (RECVASA): PRINCIPAL TASKS, EXPERIENCE OF DEVELOPMENT AND FIRST RESULTS Abstract  PDF (Eng)  similar documents
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
"... with arterial hypertension (HT), ischemic heart disease (IHD), chronic heart failure (emCHF/em) and atrial ..."
 
Vol 14, No 5 (2018) Chronic Heart Failure in Rheumatoid Arthritis Patients (Part I): Prevalence, Etiology and Pathogenesis Abstract  similar documents
D. S. Novikova, I. G. Kirillova, H. V. Udachkina, T. V. Popkova
"... , in particular, by an increased incidence of chronic heart  failure (emCHF/em). Analysis of the results of the main ..."
 
Vol 18, No 1 (2022) Polymorbidity and Polypragmasia in High and Very High Cardiovascular Risk Patients Abstract  similar documents
N. V. Izmozherova, A. A. Popov, A. A. Kuryndina, E. I. Gavrilova, M. A. Shambatov, V. M. Bakhtin
"... .  Thus,  87.5%  emCHF/em patients were receiving renin-angiotensin-aldosterone system emblockers/em. Statins were ..."
 
Vol 15, No 6 (2019) Chronic Heart Failure in Rheumatoid Arthritis Patients (Part III): Effects of Antirheumatic Drugs Abstract  similar documents
D. S. Novikova, H. V. Udachkina, I. G. Kirillova, T. V. Popkova
"... heart failure (emCHF/em) in rheumatoid arthritis (RA). The purpose of the review is to analyze the results ..."
 
Vol 4, No 2 (2008) INHIBITOR OF SYNTHESIS OF TUMOR NECROSIS FACTOR-Α, PENTOXIFYLLINE, IN COMBINED THERAPY OF THE CHRONIC HEART FAILURE Abstract  similar documents
O. P. Dudarenko, E. L. Shkol’nik, , ,
"... failure (emCHF/em) complicated ischemic heart disease (IHD). Material and methods. 55 patients with emCHF/em ..."
 
Vol 18, No 5 (2022) Insulin-like Growth Factor-1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Origin Abstract  similar documents
A. N. Zakirova, N. E. Zakirova, D. F. Nizamova
"... remodeling and fibrosis in patients with chronic heart failure (emCHF/em) of ischemic origin. Material and methods ..."
 
Vol 17, No 2 (2021) Management of Patients with Chronic Heart Failure and Diabetes Mellitus Abstract  similar documents
E. V. Reznik, T. L. Nguyen, G. N. Golukhov
"... Chronic heart failure (emCHF/em) occurs in 4.3-28% of patients with diabetes mellitus and is most often ..."
 
Vol 8, No 5 (2012) COMPARISON OF THE INFLUENCE OF LONG-TERM TREATMENT BASED ON CARVEDILOL OR BISOPROLOL ON METABOLIC PARAMETERS AND ERECTILE FUNCTION IN HYPERTENSIVE PATIENTS WITH OVERWEIGHT OR OBESITY RESULTS OF THE RANDOMIZED OPEN-LABEL PARALLEL-GROUPS STEPPED TRIAL CABRIOLET (PART 2) Abstract  similar documents
S. Y. Martsevich, S. N. Tolpigina
"... daily. If the effect was insufficient a dose of a embeta/em-emblocker/em was doubled, then amlodipine was added ..."
 
Vol 17, No 1 (2021) Transforming Growth Factor β1 and Myocardial Remodeling in Patients with Chronic Heart Failure of Ischemic Genesis Abstract  similar documents
N. E. Zakirova, A. N. Zakirova, D. F. Nizamova
"... remodeling and fibrosis in patients with chronic heart failure (emCHF/em) of ischemic origin. Material ..."
 
Vol 5, No 3 (2009) RISK FACTORS OF THE ERECTILE DYSFUNCTION IN THE PATIENTS WITH CARDIOVASCULAR DISEASES Abstract  similar documents
E. V. Minakov, R. A. Khokhlov, T. N. Kuznetsova, Y. V. Popovskaya, D. V. Snustikov, E. E. Tsareva, V. I. Yarliykova, N. M. Akhmedzhanov
"... erectile dysfunction. Age, blood pressure level, abdominal obesity, embeta/em-emblocker/em therapy and chronic heart ..."
 
1 - 100 of 371 Items 1 2 3 4 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)